Lv1
30 积分 2021-03-14 加入
Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
1天前
待确认
A cluster of type I interferon-regulated genes associates with disease activity and prognosis in patients with IgA nephropathy
3天前
已完结
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Anti-IFNAR1 Monoclonal Antibody QX006N: A First-in-Human Single Ascending Dose Study in Healthy Chinese Volunteers
3天前
已完结
Lupus nephritis: new progress in diagnosis and treatment
2个月前
已完结
Treatment of lupus nephritis: consensus, evidence and perspectives
3个月前
已完结
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study
4个月前
已完结
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study
4个月前
已完结
Global incidence and prevalence of bullous pemphigoid: A systematic review and meta‐analysis
4个月前
已完结
A cluster of type I interferon-regulated genes associates with disease activity and prognosis in patients with IgA nephropathy
4个月前
已完结
Global, regional, and national incidence and prevalence of systemic sclerosis
5个月前
已完结
皖公网安备34019202002308
